SimPath licenses novel cloning system from ORNL

SimPath2SimPath, a local start-up that pitched during Knoxville’s 2015 “Start-up Day,” has executed a license with Oak Ridge National Laboratory (ORNL) for a novel cloning system that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Click here to read the ORNL news release and look for a story profiling SimPath soon onĀ

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners